London, Ontario (February 2, 2012):...
News
London, Ontario (January 24, 2012): Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) announced today that it has completed synthesis of compounds from its...
LONDON, ONTARIO--(Marketwire -- Jan. 19, 2012) -
Sernova Corp. (TSX-V: SVA), today announced that the Japan Patent Office has issued a Notice of Allowance to Sernova for a...
London, Ontario CANADA – Sumagen Canada Inc. has been awarded a non-refundable financial contribution of up to $728,000 from the National Research Council of Canada Industrial Research ...
COTI and SERNOVA CORP at the Biotech Showcase, San Francisco
...
Ottawa - Dr. Calvin Stiller was recently named an Officer of the Order of Canada. The Order...
London, ON – The first and only preventative HIV vaccine based on a genetically modified killed whole virus has received approval by the United States Food and Drug Administration (...
LONDON, ONTARIO--(Marketwire -- November 17, 2011) - Sernova Corp. (TSX-V: SVA), is pleased to announce that it has retained Russo Partners LLC, a leading healthcare...
London, Ontario (November 1, 2011): Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT), a predictive Artificial intelligence technologiy company specializing in accelerating the...
London, Ontario (October 13, 2011): Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) announced today that a composition of matter patent has been granted by the...